Stay updated with breaking news from Research Models. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) was the recipient of a significant increase in short interest in April. As of April 30th, there was short interest totalling 1,540,000 shares, an increase of 11.6% from the April 15th total of 1,380,000 shares. Based on an average daily volume of 580,200 shares, the short-interest […]
Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) EVP Joseph W. Laplume sold 345 shares of the firm’s stock in a transaction dated Monday, May 15th. The shares were sold at an average price of $190.39, for a total transaction of $65,684.55. Following the completion of the sale, the executive vice president now owns […]
Charles River Laboratories International (NYSE:CRL – Get Rating) had its target price decreased by Credit Suisse Group from $260.00 to $255.00 in a research note released on Friday morning, The Fly reports. CRL has been the subject of a number of other research reports. Jefferies Financial Group lowered their price objective on Charles River Laboratories […]
Pinebridge Investments L.P. grew its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) by 24.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 70,020 shares of the medical research company’s stock after purchasing an additional […]
Nicholas Company Inc. trimmed its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) by 2.0% in the 4th quarter, HoldingsChannel reports. The firm owned 49,711 shares of the medical research company’s stock after selling 1,040 shares during the period. Nicholas Company Inc.’s holdings in Charles River Laboratories International were worth […]